Publications by authors named "Ole Lemming"

Claim this Profile
E
Efficacy and safety of Lu AF35700 in treatment-resistant schizophrenia: A randomized, active-controlled trial with open-label extension.
John M Kane, Bruce J Kinon, Carlos Forray, Pedro Such, Aurélia Mittoux, Ole M Lemming

Schizophr Res· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A double-blind, randomized, placebo-controlled proof of concept study of the efficacy and safety of Lu AF11167 for persistent negative symptoms in people with schizophrenia.
Andreas Meyer-Lindenberg, Jacob Nielsen, Pedro Such, Ole Michael Lemming, Janos Zambori

Eur Neuropsychopharmacol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Persistence of Nalmefene Treatment for Alcohol Dependence. Results from Two Post-authorisation Safety Studies.
Jonathan Chick, Frank Andersohn, Sylvie Guillo, Kathrin Borchert, Massoud Toussi, Ole M Lemming

Alcohol Alcohol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anxiety, irritability, and agitation as indicators of bipolar mania with depressive symptoms: a post hoc analysis of two clinical trials.
Trisha Suppes, Jonas Eberhard, Ole Lemming, Allan H Young, Roger S McIntyre

Int J Bipolar Disord· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics and Safety of Vortioxetine in Pediatric Patients.
Robert L Findling, Adelaide S Robb, Melissa DelBello, Michael Huss, Nora McNamara, Ole Michael Lemming

J Child Adolesc Psychopharmacol· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Validity of the Different Versions of the Hamilton Depression Scale in Separating Remission Rates of Placebo and Antidepressants in Clinical Trials of Major Depression.
Phillip Raphael Kyle, Ole Michael Lemming, Nina Timmerby, Susan Søndergaard, Kate Andreasson

J Clin Psychopharmacol· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Memantine in patients with Alzheimer's disease receiving donepezil: new analyses of efficacy and safety for combination therapy.
Alireza Atri, José L Molinuevo, Ole Lemming, Yvonne Wirth, Irena Pulte

Alzheimers Res Ther· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized, double-blind, placebo-controlled trial of memantine in a behaviorally enriched sample of patients with moderate-to-severe Alzheimer's disease.
Nathan Herrmann, Serge Gauthier, Neli Boneva, Ole Michael Lemming,

Int Psychogeriatr· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Memantine and brain atrophy in Alzheimer's disease: a 1-year randomized controlled trial.
David Wilkinson, Nick C Fox, Frederik Barkhof, Ravinder Phul, Ole Lemming

J Alzheimers Dis· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sertindole in the long-term treatment of schizophrenia.
Anthony S Hale, Jean M Azorin, Ole M Lemming, Eli Mæhlum

Int Clin Psychopharmacol· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Measuring therapeutic efficacy in patients with Alzheimer's disease: role of instruments.
Matthias W Riepe, Wolfgang Janetzky, Ole M Lemming

Dement Geriatr Cogn Disord· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Escitalopram prevents relapse in older patients with major depressive disorder.
Philip Gorwood, Emmanuelle Weiller, Ole Lemming, Cornelius Katona

Am J Geriatr Psychiatry· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Escitalopram prevents relapse of obsessive-compulsive disorder.
Naomi A Fineberg, Brigitte Tonnoir, Ole Lemming, Dan J Stein

Eur Neuropsychopharmacol· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Escitalopram in the long-term treatment of major depressive disorder in elderly patients.
Siegfried Kasper, Ole Michael Lemming, Hans de Swart

Neuropsychobiology· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized, double-blind, placebo-controlled study of citalopram in adolescents with major depressive disorder.
Anne-Liis von Knorring, Gunilla Ingrid Olsson, Per Hove Thomsen, Ole Michael Lemming, Agnes Hultén

J Clin Psychopharmacol· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis